v3.26.1
Condensed Consolidated Interim Statements of Changes in Redeemable Convertible Preferred Shares and Capital Deficiency Equity (Unaudited) - USD ($)
$ in Thousands
Redeemable Preferred A, A1,A2,A3, C and C-1 Shares
Preferred Stock
Series A
Preferred Stock
Serries B
Preferred Stock
Series C
Preferred Stock
Common Stock
Additional paid in capital
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 11,780 $ 2 $ 4,132 $ (34,554) $ (30,420)
Balance (in Shares) at Dec. 31, 2024 903,925 2,351,976      
Exercise of stock options and warrants [1] 2 2
Exercise of stock options and warrants (in Shares) 190,408      
Share based payments 2,255 2,255
Net Income (Loss) (5,760) (5,760)
Issuance of Series C Preferred Stock, net $ 2,431
Issuance of Series C Preferred Stock, net (in Shares) 165,633      
Conversion of SAFE (as defined below) to Series C-1 Preferred Stock $ 1,057
Conversion of SAFE (as defined below) to Series C-1 Preferred Stock (in Shares) 67,368      
Balance at Jun. 30, 2025 $ 15,268 $ 2 6,389 (40,314) (33,923)
Balance (in Shares) at Jun. 30, 2025 1,136,926 2,542,384      
Balance at Mar. 31, 2025 $ 11,780 $ 2 5,522 (37,868) (32,344)
Balance (in Shares) at Mar. 31, 2025 903,925 2,364,971      
Exercise of stock options and warrants [1] 1 1
Exercise of stock options and warrants (in Shares) 177,413      
Share based payments 866 866
Net Income (Loss) (2,446) (2,446)
Issuance of Series C Preferred Stock, net $ 2,431
Issuance of Series C Preferred Stock, net (in Shares) 165,633      
Conversion of SAFE (as defined below) to Series C-1 Preferred Stock $ 1,057  
Conversion of SAFE (as defined below) to Series C-1 Preferred Stock (in Shares) 67,368      
Balance at Jun. 30, 2025 $ 15,268 $ 2 6,389 (40,314) (33,923)
Balance (in Shares) at Jun. 30, 2025 1,136,926 2,542,384      
Balance at Dec. 31, 2025 $ 15,268 $ 2 7,332 (47,373) (40,039)
Balance (in Shares) at Dec. 31, 2025 1,136,926 3,019,557      
Conversion of redeemable preferred shares $ (15,268) [1] 15,268 15,268
Conversion of redeemable preferred shares (in Shares) (1,136,926) 4,103,962      
Exercise of stock options and warrants [1] 3 $ 3
Exercise of stock options and warrants (in Shares) 49,044     49,537
Shares issued in connection with loan agreement [1]
Shares issued in connection with loan agreement (in Shares) 2,751      
Impact of closing of Business Combination [1] [1] [1] (1,564) (1,564)
Impact of closing of Business Combination (in Shares) 5,330 10,660 4,178,485      
Shares Issued to advisors [1] 4,277 4,277
Shares Issued to advisors (in Shares) 1,630,000      
Conversion of convertible notes [1] [1] 12,676 12,676
Conversion of convertible notes (in Shares) 3,061 1,356,459      
Issuance of the private investment into public equity (“PIPE”) shares [1] 6,771 6,771
Issuance of the private investment into public equity (“PIPE”) shares (in Shares) 8,000      
Conversion of Series A Preferred Stock to common stock [1] [1] [1]
Conversion of Series A Preferred Stock to common stock (in Shares) (884) 250,024      
Reclassification of warrant to equity 390 390
Share based payments 4,431 4,431
Net Income (Loss) (14,209) (14,209)
Balance at Jun. 30, 2026 [1] [1] [1] $ 2 49,584 (61,582) (11,996)
Balance (in Shares) at Jun. 30, 2026 2,177 13,330 10,660 14,590,282      
Balance at Mar. 31, 2026 [1] [1] [1] $ 2 46,093 (58,143) (12,048)
Balance (in Shares) at Mar. 31, 2026 2,177 13,330 10,660 14,064,191      
Exercise of stock options and warrants [1]   [1]
Exercise of stock options and warrants (in Shares) 1,091      
Shares Issued to advisors [1] 3,268 3,268
Shares Issued to advisors (in Shares) 525,000      
Share based payments 223 223
Net Income (Loss) (3,439) (3,439)
Balance at Jun. 30, 2026 [1] [1] [1] $ 2 $ 49,584 $ (61,582) $ (11,996)
Balance (in Shares) at Jun. 30, 2026 2,177 13,330 10,660 14,590,282      
[1] Less than $1